Nouf H. Alsubhi

Targeting BRCA1‐BER deficient breast cancer by ATM or DNA‐PKcs blockade either alone or in combination with cisplatin for personalized therapy

Nada Albarakati, Tarek M.A. Abdel-Fatah, Rachel Doherty et al. · Molecular Oncology · 2014 · 79 citations · Full text

Checkpoint kinase1 (CHK1) is an important biomarker in breast cancer having a role in chemotherapy response

Methaq Mueen Al-kaabi, Alaa T. Alshareeda, Dena Jerjees et al. · British Journal of Cancer · 2015 · 45 citations · Full text

Clinicopathological Significance of ATM-Chk2 Expression in Sporadic Breast Cancers: a Comprehensive Analysis in Large Cohorts

Tarek M. Abdel-Fatah, Arvind Arora, Nouf H. Alsubhi et al. · Neoplasia · 2014 · 40 citations · Full text

Chk1 phosphorylated at serine345 is a predictor of early local recurrence and radio‐resistance in breast cancer

Nouf H. Alsubhi, Fiona K. Middleton, Tarek M.A. Abdel-Fatah et al. · Molecular Oncology · 2015 · 39 citations · Full text

Targeting ataxia telangiectasia-mutated- and Rad3-related kinase (ATR) in PTEN-deficient breast cancers for personalized therapy

Nouf H. Alsubhi, Reem Ali, Tarek M.A. Abdel-Fatah et al. · Breast Cancer Research and Treatment · 2018 · 30 citations · Full text